Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Levente
Levente Batizy, Litchfield Park, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20100082452 | ASSOCIATING A PRODUCT WITH A STATIC CATEGORY USING TAGS - Methods of the present invention allow a static product category to be received from a user for a product on an ecommerce site. The user may then be enabled to dynamically associate the product with the static product category using a metadata tag. | 04-01-2010 |
| 20100082453 | ASSOCIATING A PRODUCT WITH A DYNAMIC CATEGORY USING TAGS - Methods of the present invention allow a user to be enabled to create a metadata tag associated with a product on an ecommerce site. Using the metadata tag, a product category associated with the product may be dynamically created. | 04-01-2010 |
Levente Bodrossy, Toltestava HU
| Patent application number | Description | Published |
|---|---|---|
| 20090291854 | Identification of Pathogens - Disclosed is a method for identification of microbial pathogens in a body fluid sample comprising the following steps: a) providing a body fluid sample; b) lysing the microbial pathogens and performing a nucleic acid amplification reaction on the microbial DNA encoding 16S or 18S rRNA wherein or whereafter the amplified nucleic acids are labelled; c) contacting the labelled amplified nucleic acids of step b) with a microarray comprising on defined areas on the microarray's surface immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens; d) detecting the binding of one or more species of the labelled amplified nucleic acids to a probe by detecting a labelled amplified nucleic acid being specifically bound to the microarray; and e) identifying a microbial pathogen in the body fluid sample by correlating the detected binding of the labelled amplified nucleic acids with the defined areas of the immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens. | 11-26-2009 |
Levente Juhàsz, Nyiregyhaza HU
| Patent application number | Description | Published |
|---|---|---|
| 20100080950 | Aroma-therapeutic bedding set - The object of the invention is an aroma-therapeutic bedding set comprising a filling consisting of fibre fleece layers, made of natural or synthetic fibres or a mixture thereof, or fibres placed in an outside ticking, and containing preferably evenly distributed dried and cut herbs embedded in the fibres, or between the layers and embedded in the fibres of the layers. | 04-01-2010 |
Levente Juhàsz, Nyiregyhaza HU
| Patent application number | Description | Published |
|---|---|---|
| 20100080950 | Aroma-therapeutic bedding set - The object of the invention is an aroma-therapeutic bedding set comprising a filling consisting of fibre fleece layers, made of natural or synthetic fibres or a mixture thereof, or fibres placed in an outside ticking, and containing preferably evenly distributed dried and cut herbs embedded in the fibres, or between the layers and embedded in the fibres of the layers. | 04-01-2010 |
Levente Kapas, Spokane Valley, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100196396 | COMPOSITIONS AND METHODS FOR MODULATING GHRELIN-MEDIATED CONDITIONS - In certain aspects, the preproghrelin gene, but not the ghrelin receptor (GHS-R1a) is required for normal integration of thermoregulation and sleep in mice. Particular aspects provide methods for modulation of thermoregulation and other ghrelin-mediated conditions (e.g., reduction of appetite or food intake, reduction of body weight or treatment of obesity, reduction of body temperature or induction of hypothermia, etc.), comprising administration of an inhibitor of ghrelin expression, and including, e.g., siRNA inhibition for treatment of obesity and for modulation of thermoregulation (e.g., induction of hypothermia in surgical settings benefiting from same). Additionally provided are methods for reducing body temperature or induction of hypothermia, comprising administration to a mammalian subject in need thereof an amount of an anti-obestatin antibody agent sufficient to reduce body temperature or induce hypothermia. Further methods comprise administration of a ghrelin peptide antagonist. | 08-05-2010 |